A 58-year-old hypertensive man with a perfused central retinal vein occlusion of 21 days' duration received 50 microg of intravitreal recombinant tissue plasminogen activator in 0.1 cc. Best-corrected visual acuity improved 2 weeks after the injection. Optical coherence tomography and fluorescein angiography demonstrated resolution of cystoid macular edema and improvement of venous outflow. Intravitreal tissue plasminogen activator may be a useful treatment for central retinal vein occlusion with a duration of 21 days or less.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
tissue plasminogen
12
plasminogen activator
12
central retinal
12
retinal vein
12
vein occlusion
12
intravitreal tissue
8
activator treatment
8
treatment central
8
occlusion 58-year-old
4
58-year-old hypertensive
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!